CIK 0001439725
- Non-accelerated filer
- Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203986492
- Phone
- +1 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 56,782 shares at $1.15 ($65,066)
- 4 Open-market buy Director bought 29,425 shares at $1.11 ($32,529)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 3,485 shares at an average $1.57 ($5,468)
- 4 Open-market sale Chief Commercial Officer sold 1,697 shares at an average $1.57 ($2,663)
- 4 Open-market sale Chief Accounting Officer sold 2,020 shares at an average $1.57 ($3,170)
- 4 Open-market sale President & CEO sold 13,782 shares at an average $1.57 ($21,625)
- 4 Open-market sale Chief Development Officer sold 1,527 shares at an average $1.57 ($2,396)
- 4 Exercise or conversion Director acquired 145,833 shares (option exercise)
- 4 Exercise or conversion Director acquired 145,833 shares (option exercise)
- 4 Exercise or conversion Director acquired 150,711 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Development Officer sold 1,852 shares at $1.80 ($3,332)
- 4 Open-market sale President & CEO sold 16,278 shares at $1.80 ($29,286)
- 4 Open-market sale Chief Accounting Officer sold 2,016 shares at $1.80 ($3,627)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 4,220 shares at $1.80 ($7,592)
Page 10 of 17 · 336 filings